GlobeNewswire by notified

Ageas provides business update at the Investor Day in London


Ageas provides business update at the Investor Day in London

Today, Ageas held its Investor Day at which the Group provided an update on its Impact24 strategy, its performance, and other selected topics.

Ageas confirms Group commitments

Ageas reconfirmed its guidance for the 2023 net operating result to reach the upper end of the EUR 1.1 to 1.2 billion range, even taking into account the recent storms in Belgium, the UK and France. The Group also re-iterated its confidence in the operating entities’ ability to upstream more than sufficient cash to deliver on the Group’s DPS growth target of 6 to 10% set under Impact24. The Group’s solid foundation assures an attractive dividend growth in line with the Impact24 ambition also beyond this strategic cycle.

Continued growth potential in China

The business in Asia, and more specifically in China, continues to deliver a strong operating performance with excellent top line growth and sound margin developments, with a clear focus on quality over quantity. This robust performance is reflected in both the strong IFRS 17 results and Operational Capital Generation, while high New Business Value and New Business CSM are supportive of future profits. The Group is convinced of the potential of the Chinese Life, Health and Pensions Market and confirmed its participation in the recently launched capital increase tender of Taiping Pension for a 10% stake, which could represent an investment of about EUR 140 million.

Successful transformation of Ageas UK

Ageas UK has undergone a considerable and successful transformation since 2020 by making a clear choice to focus the business on the UK personal lines market and by investing in differentiating capabilities in data, technical insurance skills, technology and efficiency. As a result, Ageas UK is well positioned to build on the progress made through further growth in its chosen markets and to generate a net profit after tax of GBP 100 million by 2027.

AG’s growth story continues

As the Belgian market leader, consistently delivering strong results and sustainable growth, AG continues to see opportunities to grow in the Belgian market by entering niche markets adjacent to its core business, by remaining a frontrunner in innovative products and services and by adopting new technologies. From its strong foundation, AG aims to deliver profitable and above market growth across all its business lines in the future.

Hans De Cuyper, CEO Ageas:
Ageas is an international Group of local winners that benefit from synergies not only on the cost side but also on the revenue side, thanks to the sharing of expertise and innovative solutions in terms of sales, operations, and technology. Our diversification between regions and businesses, allows us to deliver a consistent strong performance for the future.”

The presentations and recordings from the Investor Day 2023 will be made available on the Ageas website.

Ageas is a listed international insurance Group with a heritage spanning almost 200 years. It offers Retail and Business customers Life and Non-Life insurance products designed to suit their specific needs, today and tomorrow, and is also engaged in reinsurance activities. As one of Europe's larger insurance companies, Ageas concentrates its activities in Europe and Asia, which together make up the major part of the global insurance market. It operates successful insurance businesses in Belgium, the UK, Portugal, Türkiye, China, Malaysia, India, Thailand, Vietnam, Laos, Cambodia, Singapore, and the Philippines through a combination of wholly owned subsidiaries and long term partnerships with strong financial institutions and key distributors. Ageas ranks among the market leaders in the countries in which it operates. It represents a staff force of about 44,000 people and reported annual inflows of more than EUR 16 billion in 2022.


To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Karolinska Development's portfolio company OssDsign expects fourth-quarter revenues to exceed market estimates6.12.2023 12:38:48 CET | Press release

STOCKHOLM, SWEDEN, December 6, 2023. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that the portfolio company OssDsign expects revenues for the fourth quarter of 2023 to exceed market expectations. Preliminary total revenues for the period October - November amount to SEK 25.2 million, mainly attributable to a continued strong market performance of the company's orthobiologic franchise and some extraordinary orders from a large hospital system. According to preliminary and unaudited data, sales of OssDsign Catalyst amounted to SEK 18.8 million during the period of October – November 2023, whereas OssDsign Cranial recorded sales of SEK 6.4 million. A complete financial statement for the fourth quarter will be presented in OssDsign’s year-end report for 2023, to be published on February 6, 2024. "OssDsign continues its strong growth journey, and we are confident that the company's new strategic direction to fully focus the business on its high-margin orthobiologic franchis

Karolinska Developments portföljbolag OssDsign bedömer att intäkterna för fjärde kvartalet kommer att överträffa marknadens förväntningar6.12.2023 12:38:48 CET | Pressemelding

STOCKHOLM, SVERIGE 6 december 2023. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar att portföljbolaget OssDsign bedömer att intäkterna för det fjärde kvartalet 2023 kommer överträffa marknadens förväntningar. De preliminära totala intäkterna för perioden oktober – november uppgår till 25,2 MSEK, främst till följd av en fortsatt stark marknadsutveckling för bolagets ortobiologiprodukter och ett antal större ordrar från ett stort sjukhusnätverk. Enligt preliminära och oreviderade försäljningsdata för perioden oktober – november 2023 uppnåddes intäkter om 18,8 miljoner kronor för OssDsign Catalyst, medan intäkterna för OssDsign Cranial uppgick till 6,4 miljoner kronor. En fullständig finansiell rapport för det fjärde kvartalet kommer att presenteras i OssDsigns bokslutskommuniké för 2023, som publiceras den 6 februari 2024. ”OssDsign fortsätter sin starka tillväxtresa och vi är övertygade om att bolagets nya strategiska inriktning för att fullt fokusera verksamheten på sina o

XPENG G9 Achieves a Five-Star 2023 Safety Rating from Euro NCAP6.12.2023 11:00:00 CET | Press release

The new XPENG G9, now on sale in Europe, received a five-star 2023 safety rating from Euro NCAPThis is XPENG's second five-star safety rating for an international model following the new P7 in October; and its first SUV obtained both Euro NCAP and C-NCAP five-star ratings AMSTERDAM, Dec. 06, 2023 (GLOBE NEWSWIRE) -- XPENG Motors (“XPENG” or the “Company,” NYSE: XPEV and HKEX: 9868), a leading Chinese smart electric vehicle (“Smart EV”) company, today announces that the international model of their flagship electric SUV, XPENG G9, has received a five-star 2023 safety rating from Euro NCAP. Euro NCAP's five-star safety rating system aims to help consumers, their families and businesses compare vehicles more easily and identify the safest choice for their needs. The tests, which replicate real-life road danger scenarios, represent the European gold standard for comprehensive automotive safety testing. The rating recognises the XPENG G9's advanced body structure and comprehensive passive s